Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eledon Pharmaceuticals, Inc. - Common Stock (NQ:ELDN)

1.850 -0.280 (-13.15%)
Streaming Delayed Price Updated: 3:17 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,670,645
Open 1.870
Bid (Size) 1.840 (4,600)
Ask (Size) 1.850 (3,200)
Prev. Close 2.130
Today's Range 1.710 - 1.930
52wk Range 1.430 - 5.083
Shares Outstanding 22,506,956
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Eledon Pharmaceuticals Stock Plunges Following $50 Million Public Offering
Irvine, CA – November 12, 2025 – Eledon Pharmaceuticals (NASDAQ: ELDN) witnessed a significant decline in its stock value today, plummeting by 17.8% in premarket trading. This sharp drop comes on the... 
Via MarketMinute
Topics Initial Public Offering Intellectual Property Regulatory Compliance
Top movers in Wednesday's pre-market session
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill

Performance

YTD
-56.9%
-56.9%
1 Month
-32.0%
-32.0%
3 Month
-30.5%
-30.5%
6 Month
-36.2%
-36.2%
1 Year
-62.7%
-62.7%

More News

Read More
Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
From Eledon Pharmaceuticals, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
From Eledon Pharmaceuticals, Inc.
Via GlobeNewswire
Eledon Pharmaceuticals (ELDN) Plummets Nearly 50% Amidst Mixed Phase 2 Trial Results, Sparking Investor Concern
Via MarketMinute
What's going on in today's after hours session
Via Chartmill
What's going on in today's session
Via Chartmill
Eledon Pharmaceuticals' Lead Asset Fails In Mid-Stage Study, But Pushes Forward With Pivotal Study
Via Benzinga
Dow Dips Over 200 Points; Fluor Shares Slide After Q3 Results
Via Benzinga
Topics Stocks
Keep an eye on the top gainers and losers in Friday's session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Discover the top movers in Friday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting
From Eledon Pharmaceuticals, Inc.
Via GlobeNewswire
Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
From Eledon Pharmaceuticals, Inc.
Via GlobeNewswire
Top movers in Friday's session
Via Chartmill
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting
From Eledon Pharmaceuticals, Inc.
Via GlobeNewswire
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
From Eledon Pharmaceuticals, Inc.
Via GlobeNewswire
Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025
From Eledon Pharmaceuticals, Inc.
Via GlobeNewswire
Eledon Posts Narrower Loss in Q2
Via The Motley Fool
Topics Intellectual Property
Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results
From Eledon Pharmaceuticals, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Eledon Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Eledon Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Eledon Pharmaceuticals, Inc. - Common Stock trade on?
Eledon Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Eledon Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Eledon Pharmaceuticals, Inc. - Common Stock is ELDN on the Nasdaq Stock Market
What is the current price of Eledon Pharmaceuticals, Inc. - Common Stock?
The current price of Eledon Pharmaceuticals, Inc. - Common Stock is 1.850
When was Eledon Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Eledon Pharmaceuticals, Inc. - Common Stock was at 11/12/25 03:17 PM ET
What is the market capitalization of Eledon Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Eledon Pharmaceuticals, Inc. - Common Stock is 41.64M
How many shares of Eledon Pharmaceuticals, Inc. - Common Stock are outstanding?
Eledon Pharmaceuticals, Inc. - Common Stock has 42M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.